Literature DB >> 16004709

Lymphoedema and its management in cases of lymphatic filariasis: the current situation in three suburbs of Matara, Sri Lanka, before the introduction of a morbidity-control programme.

T C Yahathugoda1, D Wickramasinghe, M V Weerasooriya, W A Samarawickrema.   

Abstract

Using in-depth interviews, information on the current state of lymphoedema management was collected from 101 cases of lymphatic filariasis with lymphoedema in three suburbs of Matara. The interviews were conducted prior to the introduction of a programme of community home-based care (CHBC) that incorporates modern lymphoedema-management strategies. Thirty-two of the interviewees had severe lymphoedema (of grade III or above). The male interviewees had significantly more entry lesions than the female. Most of the subjects had suffered from episodes of limb pain with fever, although the incidence of these episodes appeared unrelated to the severity of the lymphoedema. The frequency of the episodes of limb-pain/fever in the 12 months prior to the interviews appeared unrelated either to the level of daily hygiene, which was generally poor, or to the frequency of bathing. Many (65%) of the subjects paid no attention to limb care when bathing, and 44% did not use footwear. Over 80% made no effort to keep their afflicted limbs elevated, and 95% did not exercise. Most of the female interviewees felt shameful of their condition and were, in consequence, less likely to attend government clinics, for treatment, than the male interviewees. The drug treatment that the interviewees had received was often inadequate, and most had stopped seeking treatment because they had not perceived any significant treatment-attributable improvement in their condition. Modern lymphoedema-management strategies (based on regular washing, careful drying, and treatment, with antifungal, antibiotic or emollient creams, of the affected limbs, limb elevation, exercise, and use of footwear) had not reached the study communities and the local physicians were not aware of them. When dermatology life-quality indexes (DLQI) were calculated for the interviewees, the 26 most impaired subjects gave scores of 5-15 (mean=8.6). The DLQI for these subjects will be regularly re-evaluated, as a measure of the effectiveness of the CHBC programme that has now begun.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16004709     DOI: 10.1179/136485905X46450

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  12 in total

Review 1.  Disability measurement for lymphatic filariasis: a review of generic tools used within morbidity management programs.

Authors:  Lynne Zeldenryk; Susan Gordon; Marion Gray; Richard Speare; Wayne Melrose
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

2.  Life quality impairment caused by hookworm-related cutaneous larva migrans in resource-poor communities in Manaus, Brazil.

Authors:  Angela Schuster; Hannah Lesshafft; Sinésio Talhari; Silás Guedes de Oliveira; Ralf Ignatius; Hermann Feldmeier
Journal:  PLoS Negl Trop Dis       Date:  2011-11-08

3.  Issues in delivering morbidity management for lymphatic filariasis elimination: a study in Pondicherry, South India.

Authors:  A Krishna Kumari; Yuvaraj J; L K Das
Journal:  ScientificWorldJournal       Date:  2012-04-30

4.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15

5.  Worldwide assessment of healthcare personnel dealing with lymphoedema.

Authors:  Henrike Schulze; Marisa Nacke; Christoph Gutenbrunner; Catarina Hadamitzky
Journal:  Health Econ Rev       Date:  2018-04-16

6.  Physical disability and psychosocial impact due to chronic filarial lymphoedema in Sri Lanka.

Authors:  R S Wijesinghe; A R Wickremasinghe; Sriyani Ekanayake; M S A Perera
Journal:  Filaria J       Date:  2007-03-29

7.  Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis.

Authors:  Myrtle Perera; Margaret Whitehead; David Molyneux; Mirani Weerasooriya; Godfrey Gunatilleke
Journal:  PLoS Negl Trop Dis       Date:  2007-11-21

8.  Comparison of three quality of life instruments in lymphatic filariasis: DLQI, WHODAS 2.0, and LFSQQ.

Authors:  Cristina Thomas; Saravu R Narahari; Kuthaje S Bose; Kuthaje Vivekananda; Steven Nwe; Dennis P West; Mary Kwasny; Roopal V Kundu
Journal:  PLoS Negl Trop Dis       Date:  2014-02-20

9.  Morbidity management and disability prevention for lymphatic filariasis in Sri Lanka: Current status and future prospects.

Authors:  Nilmini Chandrasena; Ranjan Premaratna; Indeewarie E Gunaratna; Nilanthi R de Silva
Journal:  PLoS Negl Trop Dis       Date:  2018-05-10

10.  How lymphatic filariasis was eliminated from an urban poor setting in Santo Domingo, Dominican Republic.

Authors:  Manuel Gonzales; Margaret C Baker; Ana Celestino; Danerys Santa Morillo; Amy Chambliss; Sarah Adams; Margaret Gyapong; Dominique Kyelem
Journal:  Int Health       Date:  2019-03-01       Impact factor: 2.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.